- Home
- YMAB vs ATEX Comparison
YMAB vs ATEX Comparison
Compare YMAB & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- ATEX
- Stock Information
- Founded
- YMAB 2015
- ATEX 1997
- Country
- YMAB United States
- ATEX United States
- Employees
- YMAB N/A
- ATEX N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- ATEX Telecommunications Equipment
- Sector
- YMAB Health Care
- ATEX Telecommunications
- Exchange
- YMAB Nasdaq
- ATEX Nasdaq
- Market Cap
- YMAB 631.1M
- ATEX 623.7M
- IPO Year
- YMAB 2018
- ATEX N/A
- Fundamental
- Price
- YMAB $11.14
- ATEX $33.61
- Analyst Decision
- YMAB Strong Buy
- ATEX Strong Buy
- Analyst Count
- YMAB 8
- ATEX 2
- Target Price
- YMAB $21.38
- ATEX $68.00
- AVG Volume (30 Days)
- YMAB 268.9K
- ATEX 108.1K
- Earning Date
- YMAB 11-08-2024
- ATEX 11-13-2024
- Dividend Yield
- YMAB N/A
- ATEX N/A
- EPS Growth
- YMAB N/A
- ATEX N/A
- EPS
- YMAB N/A
- ATEX N/A
- Revenue
- YMAB $84,553,000.00
- ATEX $5,607,000.00
- Revenue This Year
- YMAB $10.24
- ATEX $58.60
- Revenue Next Year
- YMAB $20.21
- ATEX $5.40
- P/E Ratio
- YMAB N/A
- ATEX N/A
- Revenue Growth
- YMAB N/A
- ATEX 97.01
- 52 Week Low
- YMAB $5.17
- ATEX $29.12
- 52 Week High
- YMAB $20.90
- ATEX $42.41
- Technical
- Relative Strength Index (RSI)
- YMAB 25.01
- ATEX 48.61
- Support Level
- YMAB $12.47
- ATEX $31.01
- Resistance Level
- YMAB $15.69
- ATEX $35.12
- Average True Range (ATR)
- YMAB 0.97
- ATEX 1.11
- MACD
- YMAB -0.46
- ATEX 0.09
- Stochastic Oscillator
- YMAB 9.88
- ATEX 57.82
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.